Clinical Outcomes of Hospital-Acquired Infection with Acinetobacter nosocomialis and Acinetobacter pittii

被引:106
作者
Chusri, Sarunyou [1 ,2 ,3 ]
Chongsuvivatwong, Virasakdi [3 ]
Rivera, Jesabel I. [2 ]
Silpapojakul, Kachornsakdi [1 ]
Singkhamanan, Kamonnut [4 ]
McNeil, Edward [3 ]
Doi, Yohei [2 ]
机构
[1] Prince Songkla Univ, Fac Med, Div Infect Dis, Hat Yai, Thailand
[2] Univ Pittsburgh, Sch Med, Div Infect Dis, Pittsburgh, PA 15260 USA
[3] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Thailand
[4] Prince Songkla Univ, Fac Med, Dept Biomed Sci, Hat Yai, Thailand
基金
美国国家卫生研究院;
关键词
ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BAUMANNII; IDENTIFICATION; BACTEREMIA; EPIDEMIOLOGY; EMERGENCE; TESTS; SPP; GENE;
D O I
10.1128/AAC.02992-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The role of Acinetobacter nosocomialis and Acinetobacter pittii, which belong to the A. calcoaceticus-A. baumannii complex, in hospital-acquired infections is increasingly recognized. Here we describe a retrospective cohort study of hospital-acquired A. calcoaceticus-A. baumannii complex infections at a university hospital in Thailand. A total of 222 unique cases were identified between January 2010 and December 2011. The genomospecies of the A. calcoaceticus-A. baumannii complex isolates were classified as follows: A. baumannii, 197 (89%); A. nosocomialis, 18 (8%); and A. pittii, 7 (3%). All A. nosocomialis and A. pittii isolates were susceptible to imipenem and meropenem. The patients infected with A. nosocomialis and A. pittii had lower 30-day mortality than those infected with carbapenem-susceptible A. baumannii (P = 0.025) and carbapenem-resistant A. baumannii (P = 0.013). The factors influencing 30-day mortality were infection with non-baumannii A. calcoaceticus-A. baumannii complex (hazard ratio [HR], 0.12; 95% confidence interval [CI], 0.03 to 0.51; P = 0.004), infection with carbapenem-resistant A. baumannii (HR, 1.57; 95% CI, 0.89 to 2.79; P = 0.105), appropriate empirical antimicrobial therapy (HR, 0.38; 95% CI, 0.23 to 0.61; P < 0.001), and higher acute physiology and chronic health evaluation II (APACHE II) score (HR, 1.15; 95% CI, 1.10 to 1.19; P < 0.001). In Galleria mellonella assays, the survival rates were significantly higher for the larvae infected with A. nosocomialis or A. pittii than for those infected with either carbapenem-susceptible A. baumannii or carbapenem-resistant A. baumannii, but no differences in survival rates were observed between carbapenem-susceptible A. baumannii and carbapenem-resistant A. baumannii. These findings suggest intrinsic differences in virulence between non-baumannii A. calcoaceticus-A. baumannii complex species and A. baumannii but not between carbapenem-susceptible and resistant A. baumannii.
引用
收藏
页码:4172 / 4179
页数:8
相关论文
共 26 条
  • [11] Emergence of Carbapenem-Resistant Non-baumannii Species of Acinetobacter Harboring a blaOXA-51-Like Gene That Is Intrinsic to A. baumannii
    Lee, Yi-Tzu
    Kuo, Shu-Chen
    Chiang, Mei-Chun
    Yang, Su-Pen
    Chen, Chien-Pei
    Chen, Te-Li
    Fung, Chang-Phone
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (02) : 1124 - 1127
  • [12] Acinetobacter baumannii:: Epidemiology, antimicrobial resistance, and treatment options
    Maragakis, Lisa L.
    Perl, Trish M.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 (08) : 1254 - 1263
  • [13] Current concepts: Acinetobacter infection
    Munoz-Price, L. Silvia
    Weinstein, Robert A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12) : 1271 - 1281
  • [14] Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp nov (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp nov (formerly Acinetobacter genomic species 13TU)
    Nemec, Alexandr
    Krizova, Lenka
    Maixnerova, Martina
    van der Reijden, Tanny J. K.
    Deschaght, Pieter
    Passet, Virginie
    Vaneechoutte, Mario
    Brisse, Sylvain
    Dijkshoorn, Lenie
    [J]. RESEARCH IN MICROBIOLOGY, 2011, 162 (04) : 393 - 404
  • [15] The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies
    Park, Kyung-Hwa
    Shin, Jong-Hee
    Lee, Seung Yeop
    Kim, Soo Hyun
    Jang, Mi Ok
    Kang, Seung-Ji
    Jung, Sook-In
    Chung, Eun-Kyung
    Ko, Kwan Soo
    Jang, Hee-Chang
    [J]. PLOS ONE, 2013, 8 (06):
  • [16] Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea
    Park, Young Kyoung
    Jung, Sook-In
    Park, Kyong-Hwa
    Kim, Su Hwan
    Ko, Kwan Soo
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (01) : 81 - 85
  • [17] The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species
    Paterson, David L.
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 43 : S43 - S48
  • [18] Acinetobacter baumannii:: Emergence of a successful pathogen
    Peleg, Anton Y.
    Seifert, Harald
    Paterson, David L.
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (03) : 538 - 582
  • [19] Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics
    Peleg, Anton Y.
    Jara, Sebastian
    Monga, Divya
    Eliopoulos, George M.
    Moellering, Robert C., Jr.
    Mylonakis, Eleftherios
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (06) : 2605 - 2609
  • [20] Rongrungruang Yong, 2013, Journal of the Medical Association of Thailand, V96, pS117